Principles for designing future regimens for multidrug-resistant tuberculosis

Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes. One of the biggest barriers to scale-up is the treatment regimen, which is lengthy, complex, ineffective, poorly tolerated and expensive. For t...

詳細記述

保存先:
書誌詳細
主要な著者: Brigden, Grania, Nyang’wa, Bern-Thomas, du Cros, Philipp, Varaine, Francis, Hughes, Jennifer, Rich, Michael, Horsburgh, C Robert, Mitnick, Carole D, Nuermberger, Eric, McIlleron, Helen, Phillips, Patrick PJ, Balasegaram, Manica
フォーマット: Artigo
言語:Inglês
出版事項: World Health Organization 2014
主題:
Policy & Practice
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865549/
https://ncbi.nlm.nih.gov/pubmed/24391302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.13.122028
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料